Basic Neurosciences · Paper A
Recreational drug use
Every recreational drug is a hand on one or more transmitter faders, and the symptom it causes is what that fader does when pushed too far or let go. Cocaine and amphetamine push dopamine, so they give euphoria and then a paranoid psychosis that looks like schizophrenia'sA long-term mental illness involving episodes of psychosis such as hallucinations and delusions.Read more → positive symptoms. MDMA floods serotonin, so it gives warmth and empathy and then hyperthermia and hyponatraemia. Ketamine blocks the NMDA glutamate channel, so it gives dissociationA disconnection between a person's thoughts, feelings, memories, or sense of identity, often as a response to stress.Read more → and reproduces both positive and negative symptoms in the laboratory. Opioids act on mu receptors in reward circuits and in the brainstem, so they give euphoria and stop breathing. Cannabis works as a partial agonistA drug that activates a receptor but produces a smaller effect than a full agonist, even at a high dose.Read more → at CB1, so its psychosis risk rises with dose and potencyHow small a dose of a drug is needed to produce a given effect.Read more →, and synthetic cannabinoids, being full agonistsA drug or chemical that activates a receptor to produce an effect.Read more →, are worse. The safety claims that matter most sit on the opioid fader: toleranceNeeding a larger dose of a drug over time to get the same effect.Read more → re-trims it within weeks, abstinence resets it, and the old dose after prison or detox is an overdose.
The syllabus asks for the link between each drug's action on transmission and the mental symptoms it produces, and the link runs through the same handful of receptors and transporters every time. Stimulants raise synaptic dopamine and noradrenaline: cocaine blocks the dopamine transporter (and the noradrenaline and serotonin transporters) so released dopamine lingers, while amphetamines enter the terminal, displace dopamine from vesicles and reverse the transporter, forcing release. Both act on the mesolimbic reward pathway (taught on the reward pathway card), which is why they are reinforcing; both, at sustained high dose, produce the persecutory delusionsA fixed false belief, held with total conviction, that is not shared by the person's culture and is not changed by evidence against it.Read more →, hallucinationsSeeing, hearing, or otherwise sensing things that are not really there.Read more → and stereotyped behaviour that Connell described in his 1958 monograph on amphetamine psychosis and that antipsychotics, which lower the same fader, relieve. MDMA reverses the serotonin transporter and releases serotonin in bulk, with smaller effects on dopamine and noradrenaline: the empathy and the rise in body temperature are serotonergicRelating to serotonin, a brain chemical involved in mood.Read more →, and the hyponatraemia comes from vasopressin release combined with drinking to stay cool. Ketamine is a non-competitive antagonistA drug that blocks a receptor, stopping it from being activated.Read more → at the NMDA glutamate receptor. Krystal and colleagues (1994, Archives of General Psychiatry) showed that a sub-anaesthetic dose in healthy volunteers produces dissociationA disconnection between a person's thoughts, feelings, memories, or sense of identity, often as a response to stress.Read more →, perceptual change and negative-symptom-like withdrawal, which is why NMDA hypofunction became a second model of schizophreniaA long-term mental illness involving episodes of psychosis such as hallucinations and delusions.Read more → beside dopamine excess. Opioids are mu-receptor agonistsA drug or chemical that activates a receptor to produce an effect.Read more →: in the ventral tegmental areaA midbrain structure that is a key source of the brain's dopamine reward pathways.Read more → they silence the GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more → interneurons that restrain dopamine cells, so dopamine rises; in the brainstem they depress the respiratory drive, and that second action kills. Tetrahydrocannabinol is a partial agonistA drug that activates a receptor but produces a smaller effect than a full agonist, even at a high dose.Read more → at presynaptic CB1 receptors, which normally dampen transmitter release; the risk of psychosis tracks dose and potencyHow small a dose of a drug is needed to produce a given effect.Read more →, and synthetic cannabinoids, full agonists at the same receptor, produce more severe agitation, seizures and psychosis. Classical hallucinogens (LSD, psilocybin) act at the 5-HT2AA serotonin receptor subtype that many antipsychotic drugs block, thought to help their antidepressant and antipsychotic effect.Read more → receptor and distort perception while insightA person's awareness and understanding that they are unwell and need help.Read more → usually survives. Nitrous oxide blocks NMDA receptorsA glutamate receptor in the brain involved in learning and memory, and a target of drugs like ketamine and memantine.Read more → and, with heavy use, inactivates vitamin B12 and damages the spinal cord. GHB and its precursor GBL act at GABA-B receptors, with a withdrawal that, like alcohol's, can be fatal.
A man is found unresponsive in a hostel nine days after leaving prison. His pupils are pinpoint and he is breathing six times a minute. He took the dose he always took. The paramedic's naloxone brings him round within minutes, and forty minutes later he is drifting again. Nothing about his dose changed. What changed was inside him, and if you understand that one fact you understand the most important safety claim in this topic.
Recreational drugs are substances taken for their psychoactive effect outside medical use, and the syllabus asks you to link each one's effect on neurotransmission to the mental symptoms it produces. Six systems cover almost all of them: dopamine (stimulants), serotonin (MDMA and the classical hallucinogens), glutamate at the (ketamine, nitrous oxide), (alcohol, benzodiazepines, GHB), the mu-opioid receptor (heroin, methadone, fentanyl), and the cannabinoid CB1 receptor (cannabis and its synthetic imitations). The reward pathway they share and the GABA-A receptor each have a card of their own; here the question is what each drug does to its own system and what follows.
Nothing in a drug's receptor pharmacology tells you that the same dose becomes lethal after a gap, yet that is the claim that decides most safety stems. Opioid builds within weeks of regular use and falls within weeks of abstinence. A person leaving prison or completing detoxification has lost the tolerance and kept the memory of the dose. Merrall and colleagues (2010, Addiction) pooled the cohorts and confirmed the excess of drug-related deaths in the first two weeks after release; Strang and colleagues (2003, BMJ) showed the same danger after inpatient detoxification. The 2017 UK clinical guidelines on drug misuse and dependence (the Orange Book) answer it by recommending take-home naloxone and a spoken warning at discharge from prison or detoxification, and you should be able to give both.
Picture a sound engineer's desk with six faders, one per transmitter system, each resting at its trim. A recreational drug is a hand on a fader, and the sound is the symptom. Cocaine pushes dopamine up by blocking the transporter that would clear it (a reuptake block, so the effect lasts under an hour); amphetamines push it up by forcing release from the terminal (so the effect lasts hours). At moderate gain the sound is euphoria and alertness; at sustained high gain it is the persecutory , and stereotypies that Connell described in 1958 as amphetamine psychosis, and that antipsychotics, which pull the same fader down, relieve. Let the fader go and the crash follows: hypersomnia, hunger, , low mood.
MDMA pushes the serotonin fader by reversing the serotonin transporter (with smaller pushes on dopamine and noradrenaline). The empathy and warmth are the pleasant sound; hyperthermia, and when an or is already on the desk, are the dangerous ones; the hyponatraemia that has killed young people comes from vasopressin release plus water drunk to stay cool. Ketamine pulls the NMDA fader down, and Krystal and colleagues showed in 1994 that a sub-anaesthetic dose reproduces , perceptual change and negative-symptom-like withdrawal in healthy volunteers, the basis of the glutamate model of . Chronic ketamine use damages the bladder (ulcerative cystitis with frequency and pain on passing urine).
The opioid fader is wired to two speakers, and the desk is only trustworthy if you remember both: mu silence the interneurons that restrain dopamine cells in the , which is the reward, and they depress the brainstem respiratory drive, which is the death. Add the trim: weeks of use move it (), weeks of silence reset it (loss of tolerance), and the familiar push is now an overdose. The CB1 fader is pushed part-way by tetrahydrocannabinol, a at presynaptic receptors that normally dampen release, and fully by synthetic cannabinoids, which is why the synthetic product brings seizures, collapse and severe psychosis.
Suppose a young woman is brought in agitated. Read the pupils and the breathing before anything else: dilated pupils with tachycardia point to the dopamine fader (stimulant), constricted pupils with slow breathing to the opioid fader, and the two are never confused if you look. If she is hot, rigid and confused with a history of a pill and an antidepressant, the serotonin fader is the story, and is the label when and appear. If she is detached, staring and analgesic, the NMDA fader is down. If she has seizures and collapse after a smoked herbal product, think synthetic cannabinoid rather than cannabis.
Then predict the withdrawal by imagining the fader released. Dopamine released gives the crash. Opioid released gives dilated pupils, yawning, lacrimation, rhinorrhoea, piloerection and diarrhoea, wretched but not in itself dangerous. released, whether from alcohol, benzodiazepines or GHB, gives the withdrawal that seizes and can kill, and GHB dependence can need round-the-clock dosing to hold off. Finally, ask what the fader has done to a mental illness already present. For example, in the EU-GEI study (Di Forti and colleagues, 2019), daily cannabis use carried adjusted odds of first-episode psychosis about three times those of never-users, and daily high- use about five times; NICE CG120 says treat the psychosis and the substance use together, and never turn the person away because of the drug.
The diagnosis of intoxication or withdrawal is clinical, made from the history, the pupils, the vital signs and the mental state, with a urine drug screen as confirmation rather than the starting point (synthetic cannabinoids and many novel substances do not appear on routine screens). ICD-11 and DSM-5 (2013) both classify substance-induced psychotic disorders and withdrawal syndromes, and DSM-5 added a cannabis withdrawal syndrome. Ask every patient with psychosis about cannabis and frequency, and every opioid user about recent abstinence, prison, benzodiazepines, alcohol and gabapentinoids, because each of those multiplies the respiratory risk.
For opioid overdose: naloxone, repeated because it wears off before heroin and long before methadone, and an ambulance every time. For opioid dependence: methadone or buprenorphine as substitution under NICE TA114, psychosocial treatment including contingency management under CG51, and, as the Orange Book recommends, take-home naloxone with a spoken warning about lost at discharge from prison or detox. For psychosis with substance use: both treated, in the same service, under CG120. For stimulant psychosis: abstinence and short-term antipsychotic cover if needed, with review once the drug has cleared. For MDMA: cooling, cautious fluids, and treatment of if it declares. For GHB or alcohol withdrawal: medically supervised, because it can kill. Guidance checked on 6 September 2026.
Explain, in one sentence that names , why the fortnight after prison release is the deadliest time for an opioid user, then say what two things should leave the prison gate with him. Tolerance fell while the remembered dose did not; naloxone and the warning go with him.
Each recreational drug is a hand on a transmitter fader, the symptom is the sound that fader makes when pushed, pulled or released, and the trim that weeks of use move and weeks of abstinence reset is the fact that turns a familiar opioid dose into a fatal one.